Bank of New York Mellon’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-811,354
| Closed | -$11.7M | – | 4344 |
|
|
2026
Q1 | $11.7M | Sell |
811,354
-18,550
| -2% | -$266K | ﹤0.01% | 1851 |
|
|
2025
Q4 | $11.8M | Buy |
829,904
+10,425
| +1% | +$102K | ﹤0.01% | 1837 |
|
|
2025
Q3 | $6.46M | Buy |
819,479
+16,405
| +2% | +$117K | ﹤0.01% | 2175 |
|
|
2025
Q2 | $4.6M | Sell |
803,074
-175,239
| -18% | -$1.13M | ﹤0.01% | 2311 |
|
|
2025
Q1 | $7.98M | Sell |
978,313
-11,139
| -1% | -$103K | ﹤0.01% | 1973 |
|
|
2024
Q4 | $9.32M | Sell |
989,452
-25,876
| -3% | -$269K | ﹤0.01% | 1958 |
|
|
2024
Q3 | $10.8M | Sell |
1,015,328
-229,787
| -18% | -$2.5M | ﹤0.01% | 1881 |
|
|
2024
Q2 | $12.4M | Buy |
1,245,115
+82,065
| +7% | +$842K | ﹤0.01% | 1850 |
|
|
2024
Q1 | $13.7M | Sell |
1,163,050
-24,832
| -2% | -$318K | ﹤0.01% | 1794 |
|
|
2023
Q4 | $16.9M | Buy |
1,187,882
+5,775
| +0.5% | +$65.6K | ﹤0.01% | 1687 |
|
|
2023
Q3 | $14.4M | Buy |
1,182,107
+5,808
| +0.5% | +$74.9K | ﹤0.01% | 1729 |
|
|
2023
Q2 | $14.8M | Buy |
1,176,299
+4,944
| +0.4% | +$58.7K | ﹤0.01% | 1731 |
|
|
2023
Q1 | $13M | Sell |
1,171,355
-20,518
| -2% | -$253K | ﹤0.01% | 1792 |
|
|
2022
Q4 | $14.6M | Sell |
1,191,873
-37,691
| -3% | -$424K | ﹤0.01% | 1725 |
|
|
2022
Q3 | $12.8M | Buy |
1,229,564
+55,838
| +5% | +$622K | ﹤0.01% | 1750 |
|
|
2022
Q2 | $12.6M | Buy |
1,173,726
+44,222
| +4% | +$364K | ﹤0.01% | 1804 |
|
|
2022
Q1 | $10.7M | Buy |
1,129,504
+1,986
| +0.2% | +$18.6K | ﹤0.01% | 2037 |
|
|
2021
Q4 | $13M | Buy |
1,127,518
+7,640
| +0.7% | +$85.1K | ﹤0.01% | 1955 |
|
|
2021
Q3 | $10.7M | Buy |
1,119,878
+16,286
| +1% | +$167K | ﹤0.01% | 2084 |
|
|
2021
Q2 | $10.6M | Buy |
1,103,592
+56,428
| +5% | +$551K | ﹤0.01% | 2104 |
|
|
2021
Q1 | $10.3M | Sell |
1,047,164
-1,357,320
| -56% | -$21M | ﹤0.01% | 2070 |
|
|
2020
Q4 | $55.5M | Buy |
2,404,484
+139,270
| +6% | +$2.85M | 0.01% | 982 |
|
|
2020
Q3 | $32M | Sell |
2,265,214
-11,473
| -0.5% | -$167K | 0.01% | 1165 |
|
|
2020
Q2 | $34.3M | Buy |
2,276,687
+79,834
| +4% | +$973K | 0.01% | 1116 |
|
|
2020
Q1 | $20.3M | Sell |
2,196,853
-58,228
| -3% | -$554K | 0.01% | 1281 |
|
|
2019
Q4 | $22M | Buy |
2,255,081
+78,720
| +4% | +$721K | 0.01% | 1519 |
|
|
2019
Q3 | $17.5M | Buy |
2,176,361
+42,736
| +2% | +$464K | ﹤0.01% | 1612 |
|
|
2019
Q2 | $26.6M | Buy |
2,133,625
+106,532
| +5% | +$1.35M | 0.01% | 1374 |
|
|
2019
Q1 | $27.6M | Sell |
2,027,093
-32,260
| -2% | -$394K | 0.01% | 1353 |
|
|
2018
Q4 | $19.7M | Buy |
2,059,353
+19,000
| +0.9% | +$209K | 0.01% | 1476 |
|
|
2018
Q3 | $24.7M | Sell |
2,040,353
-6,415
| -0.3% | -$89.7K | 0.01% | 1486 |
|
|
2018
Q2 | $32M | Buy |
2,046,768
+6,931
| +0.3% | +$105K | 0.01% | 1305 |
|
|
2018
Q1 | $30.7M | Buy |
2,039,837
+1,160,301
| +132% | +$17.7M | 0.01% | 1286 |
|
|
2017
Q4 | $12.7M | Buy |
879,536
+21,352
| +2% | +$293K | ﹤0.01% | 1872 |
|
|
2017
Q3 | $12.9M | Buy |
858,184
+229,098
| +36% | +$3.03M | ﹤0.01% | 1850 |
|
|
2017
Q2 | $6.33M | Sell |
629,086
-43,377
| -6% | -$349K | ﹤0.01% | 2216 |
|
|
2017
Q1 | $4.79M | Buy |
672,463
+74,700
| +12% | +$472K | ﹤0.01% | 2349 |
|
|
2016
Q4 | $2.97M | Buy |
597,763
+10,561
| +2% | +$73.1K | ﹤0.01% | 2612 |
|
|
2016
Q3 | $4.34M | Sell |
587,202
-62,033
| -10% | -$419K | ﹤0.01% | 2303 |
|
|
2016
Q2 | $3.54M | Buy |
649,235
+107,215
| +20% | +$750K | ﹤0.01% | 2395 |
|
|
2016
Q1 | $4.58M | Sell |
542,020
-7,106
| -1% | -$50.3K | ﹤0.01% | 2222 |
|
|
2015
Q4 | $5.33M | Sell |
549,126
-30,617
| -5% | -$276K | ﹤0.01% | 2177 |
|
|
2015
Q3 | $8.11M | Sell |
579,743
-2,210
| -0.4% | -$34.7K | ﹤0.01% | 1971 |
|
|
2015
Q2 | $8.23M | Buy |
581,953
+336,991
| +138% | +$4.05M | ﹤0.01% | 2063 |
|
|
2015
Q1 | $2.67M | Sell |
244,962
-21,811
| -8% | -$192K | ﹤0.01% | 2667 |
|
|
2014
Q4 | $2.22M | Buy |
266,773
+84,544
| +46% | +$580K | ﹤0.01% | 2808 |
|
|
2014
Q3 | $1.08M | Buy |
182,229
+125,235
| +220% | +$656K | ﹤0.01% | 3242 |
|
|
2014
Q2 | $190K | Sell |
56,994
-92,828
| -62% | -$218K | ﹤0.01% | 3854 |
|
|
2014
Q1 | $310K | Sell |
149,822
-1,758
| -1% | -$4.4K | ﹤0.01% | 3733 |
|
|
2013
Q4 | $356K | Buy |
151,580
+4,388
| +3% | +$9.63K | ﹤0.01% | 3692 |
|
|
2013
Q3 | $341K | Sell |
147,192
-869
| -0.6% | -$2.18K | ﹤0.01% | 3641 |
|
|
2013
Q2 | $345K | Buy |
+148,061
| New | +$455K | ﹤0.01% | 3625 |
|
Other funds holding FOLD
Bank of New York Mellon's FOLD Position: Q2 2026 in Review
Bank of New York Mellon sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 811,354 shares — an estimated $11.7M sold.
Bank of New York Mellon first reported a position in FOLD in Q2 2013 and held it in 52 quarters. The position peaked at $55.5M in Q4 2020. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- Bank of New York Mellon reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Bank of New York Mellon sold 811,354 Amicus Therapeutics shares in Q2 2026, an estimated $11.7M.
- Bank of New York Mellon first reported a position in Amicus Therapeutics in Q2 2013 and held it in 52 quarters.
- Bank of New York Mellon's Amicus Therapeutics position peaked at $55.5M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.